Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formation

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Li, Ning ^a   Zheng, Yi Bo ^b   Han, Jie ^a   Liang, Wei ^b   Wang, Jia Yi ^a   Zhou, Jie Ru ^a   Shen, Yi ^a   Zhang, Jie ^a  

^a TONGJI UNIVERSITY   (China)

^b NINGBO FIRST HOSPITAL   (China)

Author keywords

Bone density; Bone metabolic marker; Osteoporosis; Preptin

Indexed keywords

PREPTIN; PROTEIN; TRACP 5B PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PROTEIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ACID PHOSPHATASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMUR NECK; HIP JOINT; HUMANS; INSULIN-LIKE GROWTH FACTOR II; ISOENZYMES; LINEAR MODELS; LUMBAR VERTEBRAE; MALE; MULTIVARIATE ANALYSIS; OSTEOGENESIS; OSTEOPOROSIS; PEPTIDE FRAGMENTS;

EID: 84873034708     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-49     Document Type: Article

References (25)

1. Osteoporosis: impact on health and economics. Harvey N, Dennison E, Cooper C, Nat Rev Rheumatol 2010 6 99 105 20125177
2. Osteoblastogenesis regulation signals in bone remodeling. Zuo C, Huang Y, Bajis R, Sahih M, Li YP, Dai K, et al. Osteoporos Int 2012 23 1653 1663 10.1007/s00198-012-1909-x 22290242
3. Epidemiology worldwide. Melton LJ 3rd, Endocrinol Metab Clin 2003 32 1 13 10.1016/S0889-8529(02)00061-0
4. Therapeutic approaches to bone diseases. Rodan GA, Martin TJ, Science 2000 289 1508 1514 10.1126/science.289.5484.1508 10968781
5. Low Turnover Osteoporosis in Sheep Induced by Hypothalamic-Pituitary Disconnection. Beil FT, Oheim R, Barvencik F, Hissnauer TN, Pestka JM, Ignatius A, et al. J Orthop Res 2012 30 1254 1262 10.1002/jor.22066 22234948
6. Molecular Aspects of Adipokine-Bone Interactions. Magni P, Dozio E, Galliera E, Ruscica M, Corsi MM, Curr Mol Med 2010 10 522 532 20642443
7. Mechanisms of anabolic therapies for osteoporosis. Canalis E, Giustina A, Bilezikian JP, N Engl J Med 2007 357 905 916 10.1056/NEJMra067395 17761594
8. Building bone to reverse osteoporosis and repair fractures. Khosla S, Westendorf JJ, Oursler MJ, J Clin Invest 2008 118 421 428 10.1172/JCI33612 18246192
9. Salvianolic Acid B Prevents Bone Loss in Prednisone-Treated Rats through Stimulation of Osteogenesis and Bone Marrow Angiogenesis. Cui L, Li T, Liu Y, Zhou L, Li P, Xu B, et al. PLoS One 2012 7 34647 10.1371/journal.pone.0034647 22493705
10. Teriparatide Increases Bone Mineral Density in a Man with Osteoporosis Pseudoglioma. Arantes HP, Barros ER, Kunii I, Bilezikian JP, Lazaretti-Castro M, JBMR 2011 26 2823 2826 10.1002/jbmr.530
11. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB, Natl Acad Sci USA 1987 84 8628 8632 10.1073/pnas.84.23.8628
12. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Buchanan CM, Phillips AR, Cooper GJ, Biochem J 2001 360 431 439 10.1042/0264-6021:3600431 11716772
13. Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts. Liu YS, Lu Y, Liu W, Xie H, Luo XH, Wu XP, Yuan LQ, Liao EY, Amino Acids 2010 38 763 769 10.1007/s00726-009-0281-4 19333718
14. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Yang GY, Li L, Chen WW, Liu H, Boden G, Li K, Ann Med 2009 41 52 56 10.1080/07853890802244142 18618352
15. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. Cornish J, Callon KE, Bava U, Watson M, Xu X, Lin JM, et al. Am J Physiol Endoc M 2007 292 117 E122
16. Treatment of postmenopausal osteoporosis. Eastell R, N Engl J Med 1998 338 736 746 10.1056/NEJM199803123381107 9494151
17. Bone mineral density and vertebral fractures in men. Legrand E, Chappard D, Pascaretti C, Duquenne M, Rondeau C, Simon Y, et al. Osteoporos Int 1999 10 265 270 10.1007/s001980050225 10692973
18. Pathophysiology of osteoporosis. Heaney RP, Endocrinol Metab Clin 1998 27 255 265 10.1016/S0889-8529(05)70004-9
19. Update on primary osteoporosis. Hurley DL, Khosla S, Mayo Clin Proc 1997 72 943 949 9379699
20. Osteoporosis in elderly men and women: Effects of dietary calcium, physical activity and body index. Nguyen TV, Center JR, Eisman JA, J Bone Miner Res 2000 15 322 331 10703935
21. A neuro (endo)crine regulation of bone remodeling. Amling M, Takeda S, Karsenty G, Bioessays 2000 22 970 975 10.1002/1521-1878(200011)22:11<970:: AID-BIES3>3.0.CO;2-L 11056473
22. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Chien KR, Karsenty G, Cell 2005 120 533 544 10.1016/j.cell.2005.02.006 15734685
23. High glucose concentrations alter the biomineralization process in human osteoblastic cells. García-Hernández A, Arzate H, Gil-Chavarría I, Rojo R, Moreno-Fierros L, Bone 2012 50 276 288 10.1016/j.bone.2011.10.032 22086137
24. Fat and bone. Reid IR, Arch Biochem Biophys 2010 503 20 27 Wong IP 10.1016/j.abb.2010.06.027 20599663
25. Gastrointestinal peptides and bone health. Baldock PA, Herzog H, Curr Opin Endocrinol Diab Obes 2010 17 44 50